Positive response to new AMD drug

A drug that improves vision in patients with wet age-related macular degeneration has been highlighted at a meeting of retina specialists.

Data from clinical trials of Novartis' ranibizumab treatment shows 95 per cent of patients in the first year of a two-year trial maintained or